COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08BMO
|
|||
Drug Name |
Resveratrol
|
|||
Synonyms |
Resveratrol; Resvida; KUC104385N; R 5010; SRT 501; Cis-resveratrol; PREVENTION 8 (RESVERATROL); RM-1812; SRT-501; Trans-resveratrol; CU-01000001503-3; KSC-10-164; Resveratrol-3-sulfate; Trans-3,4',5-trihydroxystilbene; Trans-3,4′,5-Trihydroxystilbene; Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Preclinical | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Company |
Sirtris Pharma
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H12O3
|
|||
Canonical SMILES |
C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
|
|||
InChI |
1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
|
|||
InChIKey |
LUKBXSAWLPMMSZ-OWOJBTEDSA-N
|
|||
CAS Number |
CAS 501-36-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
6374, 458391, 584207, 611168, 837578, 855986, 866574, 7890614, 8145576, 10299643, 10321586, 11537676, 12015089, 14822845, 17388746, 17405667, 22388006, 24278055, 24715042, 24860876, 26512266, 26612338, 26679661, 26697115, 26736772, 26747076, 26747077, 26751586, 26751587, 26759440, 29204531, 36887952, 46386962, 46493745, 46504705, 47291249, 47515445, 47589112, 47959898, 48035263, 48035264, 48185110, 48185111, 48334633, 48424038, 48425593, 49661756, 49698529, 49734167, 49833229
|
|||
ChEBI ID |
CHEBI:45713
|
References | Top | |||
---|---|---|---|---|
1 | Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 2017 Feb 13;17(1):144. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.